Cardiol Therapeutics Inc.

NASDAQ:CRDL

Drug Manufacturers - Specialty & Generic

Healthcare
$0.95 -0.47%

-$0.01 today

Market cap
$114.64M
Beta
0.80
P/E (TTM)
-4.5
EPS (TTM)
-$0.33
52W Low $0.88High $1.71

Volume 0.31M

Average 0.68M

CRDL Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Cardiol Therapeutics Inc.NASDAQ: CRDL

Retained Earnings · Q1 FY2026 · quarter ended Mar 2026

Retained earnings remains negative

Q1 FY2026 retained earnings was -CA$224.47M, compared with -CA$187.54M a year earlier.

Context

  • Retained earnings amounted to 712.9% of total assets at the end of Q1 FY2026, down 23.9 pp from a year earlier.
  • Retained earnings grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether retained earnings keeps falling in the next quarterly balance sheet after a -19.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$224.47M-5.3% QoQ
Last fiscal yearDec 2025
-CA$213.07M-18.9% YoY
Year agoMar 2025
-CA$187.54M-19.7% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-19.7%——
1 year-18.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

CAD · from the balance sheet

Latest · FY2025
(213.07M) CAD
Year-over-year change
-18.9%

Retained Earnings vs competitors

How CRDL compares with its peers on the latest reported figures

  • Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -19.7% is the 8th highest of 10, against a peer median of -13.3%.
  • Retained earnings amounts to 712.9% of total assets for CRDL, versus a peer median of 341.9%.
CRDL Competitors
Retained Earnings for CRDL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MBOTMicrobot Medical Inc.Mar 2026-$107.76M USD-15.2%—138.0%
VANIVivani Medical, Inc.Mar 2026-$155.31M USD-21.1%—366.7%
KLRSKalaris Therapeutics IncMar 2026-$170.86M USD-34.8%—155.6%
CRDLCardiol Therapeutics Inc.Mar 2026-CA$224.47M CAD-19.7%—712.9%
IMAImageneBio IncMar 2026-$240.67M USD+29.3%—176.1%
INCRInterCure Ltd.Dec 2025-₪314.62M ILS-13.3%—45.6%
HYPRHyperfine, Inc.Mar 2026-$338.64M USD-11.4%—561.2%
IFRXInflaRx N.V.Mar 2026-€383.82M EUR-12.7%—784.3%
CNTBConnect Biopharma Holdings LimitedDec 2025-$400.84M USD-16.1%—714.8%
ASRTAssertio Holdings, Inc.Mar 2026-$722.36M USD-5.2%—341.9%
Peer median (excluding CRDL) —-13.3%—341.9%

Competitors are the stored peer set for CRDL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents83.9M43.83M34.93M30.58M21.42M
Short-term Investments045.65K000
Net Receivables65.74K354.24K279.87K361.62K226.2K
Inventory00000
Other Current Assets341.39K0000
Total Current Assets87.14M45.32M36.15M31.67M23.5M
Property, Plant & Equipment (Net)356.49K218.17K337.06K195.59K118.09K
Goodwill00000
Intangible Assets379.25K217.48K210.36K00
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets735.74K435.64K547.42K195.59K118.09K
Total Assets87.88M45.76M36.7M31.86M23.62M
Account Payables4.14M6.16M7.62M6.98M0
Short-term Debt037.21K000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities6.66M1.04M238.18K05.62M
Total Current Liabilities11.57M7.23M8.3M7.01M5.66M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities(0)0000
Total Non-current Liabilities72.87K16.54K158.53K125.52K87.18K
Total Liabilities11.64M7.25M8.45M7.14M5.74M
Common Stock142.92M108.84M148.52M179.34M201.87M
Retained Earnings(83.52M)(84.43M)(142.58M)(179.25M)(213.07M)
Accumulated OCI4.18M2.6M3.52M00
Other Stockholders Equity8290(666)00
Minority Interest00000
Total Equity76.24M38.51M28.25M24.73M17.88M
Total Debt117.58K53.76K174.34K158.53K125.52K
Net Debt(83.78M)(43.77M)(34.76M)(30.42M)(21.29M)

Cardiol Therapeutics Inc.

NASDAQ:CRDL

Intrinsic Alpha fair value

Locked

Current Price

$0.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.